Last updated on June 2017

Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis


Brief description of study

The purpose of this study is to evaluate the safety of intravenous infusion of fucosylated autologous bone marrow cells as a new therapy in patients with established osteoporosis by a prospective, single-center, open, non-randomized and unblinded clinical trial.

Clinical Study Identifier: NCT02566655

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Luis F Linares Ferrando, MD

Hospital Cl nico Virgen de la Arrixaca
El Palmar, Spain
  Connect »